In this webinar, Thermo Fisher Scientific describe how they are mobilizing to meet rapidly growing demand for AAV vector from both technology development and manufacturing strategy viewpoints.
In this webinar, you'll learn more about the performance characteristics of a true pan-tropic AAV resin—POROS CaptureSelect AAVX
In this webinar, we share the development and validation of a new, and highly sensitive and accurate solution for detecting and quantifying residual HEK293 host cell DNA to help meet regulatory requirements.
Watch this educational webinar and learn how recent innovation can help you to significantly push the boundaries of viral vectors productivity and quality.
Learn about the unique features and advantages of our HyPerforma Single-Use Fermentor, the first single-use system specifically engineered for microbial fermentation.
A case study demonstrates that affinity chromatography can offer efficiency and scalability for gene therapy manufacturing using viral vectors.
Learn more about Capture Select technology minimizing the steps in the purification process.
In moving processes from bench to pilot and ultimately production fermentors, it is critical to have a reliable scaledown model.
The manufacturing of plasmid DNA is becoming a supply bottleneck due to rapidly growing demand for various gene-targeting biotherapeutics.
With the advancement of gene delivery vectors and gene editing technologies, cell and gene therapies are a very real solution to many previously untreatable or difficult to treat diseases